Stanford RAD-AT Study (Research on Anxiety and Depression - Anhedonia Treatment)
Public ClinicalTrials.gov record NCT02220309. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Neural Dimensions of Threat Reactivity and Regulation for Understanding Anxiety
Study identification
- NCT ID
- NCT02220309
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Stanford University
- Other
- Enrollment
- 167 participants
Conditions and interventions
Conditions
Interventions
- Pramipexole Oral Tablet Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 10, 2013
- Primary completion
- Dec 17, 2024
- Completion
- Apr 1, 2025
- Last update posted
- Jan 4, 2026
2013 – 2025
United States locations
- U.S. sites
- 3
- U.S. states
- 1
- U.S. cities
- 3
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Gronowski Center-5150 El Camino Real | Los Altos | California | 94022 | — |
| VAPAHCS/Palo Alto MIRECC-3801 Miranda Avenue | Palo Alto | California | 94304 | — |
| Stanford University Department of Psychiatry | Stanford | California | 94305 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02220309, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 4, 2026 · Synced May 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02220309 live on ClinicalTrials.gov.